Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

43.23
Delayed Data
As of Dec 02
 +0.01 / +0.02%
Today’s Change
31.25
Today|||52-Week Range
57.82
-23.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues0.0015.0M0.000.00
 
 
Depreciation And Amortization270.0K276.0K324.0K408.0K
 
 
 
 
 
 
Operating ExpensesGross Income-270.0K---324.0K-408.0K
 
 
 
 
General Expenses30.5M35.6M41.5M38.0M
 
 
 
 
 
Research And Development21.8M23.9M26.9M20.9M
 
 
 
 
 
Total Operating Expenses30.7M35.9M41.8M38.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.7M-20.9M-41.8M-38.4M
 
 
 
 
 
Other Expenses849.0K856.0K868.0K844.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-29.3M-19.3M-40.3M-36.9M
 
 
 
 
 
Net Income-29.3M-19.3M-40.3M-36.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS86.2M86.5M86.7M86.8M
 
 
 
 
 
Shares To Calculate EPS Diluted86.2M86.5M86.7M86.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.22-$0.46-$0.43
 
 
 
 
 
EPS Diluted-$0.34-$0.22-$0.46-$0.43